Arnatar
Arnatar Therapeutics Inc. is a San Diego-based biotechnology company founded in 2021 by Dr. Xuehai Liang and Dr. Yanfeng Wang. The company specializes in developing RNA-based therapies using its proprietary DARGER™ platform, which combines gene silencing with the ability to upregulate protein expression.
B2X
Email Address
info@arnatar.com
Founder
Latest Funding Round Date
August 25, 2025
Latest Funding Round Amount (USD)
52,000,000
Latest Funding Type
Location
Number of Employees (Ranges)
11 – 50
Phone Number
+18587577299
Total Funding Amount (USD)
52,000,000
Twitter URL
Official Website
Find more companies like Arnatar
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.